Postpartum pharmacokinetics of peramivir in the treatment of 2009 H1N1 influenza

Obstetrics and Gynecology

Volumn 118, Issue 2 PART 2, 2011, Pages 463-467

  Clay, Patrick G ^a,b,c,d   Adiga, Raghavendra B ^a,b,c,d   Taylor, Tracey A H ^a,b,c,d   Alsup, Rachael ^a,b,c,d   Gerk, Phillip M ^a,b,c,d   McRae, MaryPeace ^a,b,c,d  

^a KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

^b Liberty Hospital   (United States)

^c ST LOUIS COLLEGE OF PHARMACY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HYPERTENSIVE FACTOR; OSELTAMIVIR; PERAMIVIR;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CESAREAN SECTION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; HEALTH CARE FACILITY; HOSPITALIZATION; HUMAN; INFLUENZA A (H1N1); INTERSTITIAL LUNG DISEASE; LUNG INSUFFICIENCY; PARALYTIC ILEUS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PUERPERIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORAX RADIOGRAPHY;

ADULT; ANTIVIRAL AGENTS; CESAREAN SECTION; CYCLOPENTANES; DISEASE OUTBREAKS; FEMALE; GUANIDINES; HUMANS; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; OSELTAMIVIR; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79961038048     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31821b1b3e     Document Type: Article

References (8)

1. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009;374: 451-8.
2. Louie JK, Acosta M, Jamieson DJ, Honein MA, et al. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med 2010;362:27-35.
3. U.S. Food and Drug Administration. EUA fact sheet for health care providers. Available at: http://www.fda.gov/downloads/drugs/drugsafety/ postmarketdrugsafetyinformationforpatient sandproviders/ucm187811.pdf.
4. Lindegardh N, Hanpithakpong W, Phakdeeraj A, Singhasivanon P, Farrar J, Hien TT, et al. Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma. J Chromatogr 2008;1215:145-51.
5. Dunlop W. Serial changes in renal haemodynamics during normal human pregnancy. Br J Obstet Gyn 1981;88:1-9. (Pubitemid 11184002)
6. Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005; 44:989-1008. (Pubitemid 41356388)
7. Goldkind SF, Sahin L, Gallauresi B. Enrolling pregnant women in research-lessons from the H1N1 influenza pandemic. N Engl J Med 2010;362:2241-3.
8. Saleeby E, Chapman J, Morse J, Bryant A. H1N1 influenza in pregnancy: cause for concern. Obstet Gynecol 2009;114:885-91.